Lupus

Article	Citations
Optical coherence tomography angiography findings of systemic lupus erythematosus patients and the effect of neuropsychiatric involvement on it	43
Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study	40
Polyneuritis cranialis as a unique initial presentation of juvenile systemic lupus erythematosus: Case report	30
Associations between blood IL-33 levels and IL-33 gene polymorphisms with susceptibility to systemic lupus erythematosus: A meta-analysis	24
New-onset lupus nephritis associated with COVID-19 infection	23
Analysis of 5-year hospitalization data of patients with systemic lupus erythematosus: Damage is a risk factor for frequent and longer stays	23
Risk of Bloodstream Infection in Patients with Systemic Lupus Erythematosus Exposed to Prolonged Medium-to-High-Dose Glucocorticoids	21
Severe infections in patients with systemic lupus erythematosus from Tunisia: Prevalence and risk factors	21
Prevalence, clinical features, and possible associated factors of mesenteric vasculitis occurrence in patients with systemic lupus erythematosus: An age-, year-at SLE diagnosis, and disease duration-c	20
Lymphoid interstitial pneumonia in a patient with systemic lupus erythematosus: Case report and literature review	20
Application of Bayesian statistics to support approval of intravenous belimumab in children with systemic lupus erythematosus in the United States	19
Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations	19
Systemic lupus international collaborating clinics-2012 and European league against rheumatism/American college of rheumatology-2019 classification criteria for systemic lupus erythematosus associated	19
Long COVID in patients with systemic lupus erythematosus: A case-control study	18
Intestinal involvement in lupus: From pathophysiology to therapeutic perspectives	18
Neuropsychiatric manifestations are associated with increased mortality in Indian patients with lupus: A single centre retrospective observational study	17
The challenges in diagnosing pediatric primary antiphospholipid syndrome	17
Investigating the role of IL-6 in the pathogenesis of systemic lupus erythematosus: Insights from bone marrow mesenchymal stem cells	17
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)	17
Patient-reported disease impact of systemic lupus erythematosus with active joint symptoms: Results from the systemic lupus erythematosus-update survey	16
The correlation between pregnancy, disease activity and adverse pregnancy outcomes in patients with systemic lupus erythematosus	16
Low disease activity state in juvenile-onset systemic lupus erythematosus	15
Reversible dilated cardiomyopathy in systemic lupus erythematosus: A case report	15
Naomi Rothfield, MD, MACR 1929-2023	15
Cardiac magnetic resonance feature tracking evaluates left atrial strain in patients with systemic lupus erythematosus and mitral regurgitation	15

Exploring gastrointestinal manifestations in childhood onset systemic lupus erythematosus - Insights from a multicenter study	15
Obinutuzumab in patients with repeated lupus nephritis flares: A case series	15
Risk factors associated with COVID-19 in systemic lupus erythematosus: Results from a longitudinal prospective cohort	14
Repeat kidney biopsy findings of lupus nephritis patients in clinical remission treated with Mycophenolate associated with Belimumab or Mycophenolate plus standard of care therapy. A “post-hoc” analys	14
Prevalence of migraine in systemic lupus erythematosus: A meta-analysis	14
Thanks to Reviewers	14
Considering belimumab during pregnancy: A more viable option over time	14
Electronic health record data use in the assessment of quality indicators for glucocorticoid osteoporosis screening in systemic lupus erythematosus	13
Growth arrest-specific protein 6 as a marker of nephritis in systemic sclerosis and juvenile systemic lupus erythematosus patients	13
Depression in systemic lupus erythematosus: A manifestation of microcirculation dysfunction?	13
Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis	12
A qualitative investigation of the experiences of patients living with antiphospholipid antibodies	12
DNA methylation alterations in systemic lupus erythematosus: A systematic review of case-control studies	12
Ocular involvement in primary antiphospholipid syndrome: results of an extensive ophthalmological evaluation performed in the APS-Rio cohort	12
An ecological approach to understanding and addressing health inequities of systemic lupus erythematosus	12
Exploring the role of LIAS-related cuproptosis in systemic lupus erythematosus	12
Porphyromonas gingivalis amount in the tongue biofilm is associated with erosive arthritis in systemic lupus erythematosus	12
The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study	12
Diagnostic and clinical implications of PARP9 promoter methylation in systemic lupus erythematosus and rheumatoid arthritis	12
Systemic lupus erythematosus with diffuse intracranial calcification: A case report and review of literature	11
Comparison of hydroxychloroquine titers measured in frozen/thawed serum and whole blood obtained from lupus patients	11
Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey	11
Steroid-free flare management of a severe cutaneous lupus flare with anifrolumab	11
Pulmonary thromboembolism and alveolar hemorrhage as initial manifestations of systemic lupus erythematosus	11
The Type 1 & 2 systemic lupus erythematosus model: Perspectives of people living with systemic lupus erythematosus	11
“Long COVID in patients with systemic lupus erythematosus: A case‒control study”—a methodological consideration	11
Level of CD4 + central memory T cells and its clinical correlation in childhood-onset systemic lupus erythematosus	11
Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus	11
Analysis of clinical, immunological characteristics, damage, and survival in 300 Turkish systemic lupus erythematosus patients	11
Serologic phenotypes distinguish systemic lupus erythematosus patients developing interstitial lung disease and/or myositis	11
Estimating glucocorticoid-related morbidity in lupus nephritis using the glucocorticoid toxicity index	11
Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome	10
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort	10
Reduced circulating Tregs and positive pANCA were robustly associated with the occurrence of antiphospholipid syndrome in patients with systemic lupus erythematosus	10
Ventricular-arterial coupling in systemic lupus erythematosus women without cardiovascular risk factors	10
Dietary patterns and life-styles of patients with gastrointestinal involvement of systemic lupus erythematosus: Questionnaire survey from a tertiary center of China	10
Does the standard proteinuria cut-off for renal biopsy in lupus nephritis as per the current guidelines hold good for Asian population? A single-centre study from South India	10
Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses	10
Real-world treatment patterns of immunosuppressants in Adults with systemic lupus erythematosus: A claims database analysis in the United States	10
The (reverse) paradox of lupus anticoagulant: A case report	10
Early onset left ventricular remodeling in juvenile systemic lupus erythematosus; Insight from 3-dimensional speckle tracking echocardiography	10
Induction treatment for lupus nephritis at a high-complexity hospital in Chile	10
Downregulation of circETS1 disrupts Th17/Treg homeostasis by inhibiting FOXP3 transcription: A new potential biomarker in systemic lupus erythematosus	10
Risk stratification for infection during immunosuppressive therapy in patients with lupus nephritis: A nested case-control study	9
Epidemiology and outcomes of emergency department visits in systemic lupus erythematosus: Insights from the nationwide emergency department sample (NEDS)	9
A novel long noncoding RNA ENST00000597482 serves as a potential biomarker for disease activity and diagnosis of systemic lupus erythematosus	9
Factors mediating cancer risk in systemic lupus erythematosus	9
Adherence patterns to medications and their association with subsequent hospitalization in adult Egyptian patients with systemic lupus erythematosus	9
Systemic lupus erythematosus and antiphospholipid syndrome with retiform purpura as the initial skin lesion: A case study	9
Thrombocytopenia in systemic lupus erythematosus real-world insights from the nationwide RISE database	9

Anti-SARS-CoV-2 mRNA vaccination among patients living with SLE in Sweden: Coverage and clinical effectiveness	9
Differences and similarities of proliferative and non-proliferative forms of biopsy-proven lupus nephritis: Single centre, cross-disciplinary experience	9
A 5–year follow-up of pulmonary function tests in childhood-onset systemic lupus erythematosus: a single-center retrospective study	8
Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous	8
Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus: A meta-analysis	8
KRAS-associated pediatric lupus: Expanding the genomic landscape of monogenic lupus	8
A rare case of late-onset spondyloenchondrodysplasia with immune dysregulation presenting as adult-onset monogenic lupus	8
T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain as a promising immune checkpoint target for the treatment of SLE	8
Higher body mass index and disease duration are associated with increased risk of left ventricular diastolic dysfunction in women with systemic lupus erythematosus	8
Membranous lupus nephritis secondary to secukinumab therapy: A case report and literature review	8
Primary antiphospholipid syndrome with and without limb ischemia: A retrospective observational study	8
Factors associated with poor outcomes in SLE patients with COVID-19: Data from ReumaCoV-Brazil register	8
Disease exacerbation and COVID-19 following mRNA COVID-19 vaccination in adolescents with Systemic Lupus Erythematosus	8
Non-pharmacologic therapies in treatment of childhood-onset systemic lupus erythematosus: A systematic review	8
A single-center model for implementation of SLEDAI documentation adherence in childhood-onset systemic lupus erythematosus (cSLE)	8
Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: Results from a nationwide health registry	8
Prognostic factors of systemic lupus erythematosus patients with pulmonary embolism: An 11-year cohort study	8
Progenitor cells and circulating endothelial cells are associated with disease activity and damage in systemic lupus erythematosus patients	8
The effect of community-acquired pneumonia on myocardial injury in systemic lupus erythematosus: Insights from cardiac magnetic resonance	8
Proportion, domains, and risk factors of cognitive impairment in systemic lupus erythematosus	8
Evaluation of thyroid dysfunction in childhood-onset systemic lupus erythematosus: Risk factors for Hashimoto’s thyroiditis	8
Epidemiology of disease-activity related ophthalmological manifestations in Systemic Lupus Erythematosus: A systematic review	8
Omega-3 fatty acids: Current insights into mechanisms of action in systemic lupus erythematosus	8
Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII	8
Research progress in functional magnetic resonance imaging assessment of lupus nephritis kidney injury	8
Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review	8
Long-term outcome and predictors of long-term outcome in patients with lupus nephritis managed at a tertiary hospital in Mumbai	8
Definition and application of systemic lupus erythematosus disease modification in emerging markets: Delphi panel consensus recommendations	8
Association between cognitive impairment and olfactory deficits in systemic lupus erythematosus without major neuropsychiatric syndromes	8
Lupus nephritis and pregnancy: Diagnosis, prognosis, and management	8
Correspondence on “relationship between the EULAR/ACR classification criteria and organ damage in systemic lupus erythematosus” by Chi Chiu Mok et al	8
Predictive model of risk and severity of enteritis in systemic lupus erythematosus	8
Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study	7
Complement C4d as a biomarker for systemic lupus erythematosus and lupus nephritis	7
Cost-effectiveness analysis of treatments for the first episode of catastrophic antiphospholipid syndrome: A study based on the catastrophic antiphospholipid syndrome registry	7
Network pharmacology and molecular docking to elucidate the common mechanism of hydroxychloroquine treatment in lupus nephritis and IgA nephropathy	7
Oral lesions of systemic lupus erythematosus: A collaborative Latin American study	7
Regarding the efficacy of the COVID-19 vaccine in pediatric systemic lupus erythematosus patient	7
Determinants of sexual function in male patients with systemic lupus erythematosus	7
Cell activation, PD-1 expression and in vitro cytokine production in patients with juvenile systemic lupus erythematosus	7
Life expectancy and death pattern associated with systemic lupus erythematosus diagnosis in Brazil between 2000 and 2019	7
Sustained depression of B cell counts in lupus nephritis after treatment with rituximab and/or belimumab is associated with fewer disease flares	7
Cytomegalovirus infection and disease in systemic lupus erythematosus patients at a high-complexity hospital in southwestern Colombia	7
Mitochondrial bioenergetic changes in systemic lupus erythematosus immune cell subsets: Contributions to pathogenesis and clinical applications	7
Treatment adherence and quality of life in colombian patients with lupus nephritis	7
Early diagnosis of lupus: A possibilty. A multicentric study from SLE Special Interest Group (SIG) of Indian Rheumatology Association (IRA)	7
Korean LupusPRO: Cross-Cultural validation study for systemic lupus erythematosus	7
MBL2 gene polymorphisms and its relation to infection in Brazilian systemic lupus erythematosus patients: A 10-years follow-up study	7
Epstein-Barr virus infection and its association with systemic lupus erythematosus: Systematic review and meta-analysis	7
Premature ovarian failure in juvenile systemic lupus erythematosus patient: A rare presentation	7
Healthcare costs of systemic lupus erythematosus in New Zealand	7
Examination of antinuclear antibody staining patterns and titers in patients with childhood-onset systemic lupus erythematosus	7
Intravenous immunoglobulin as a treatment for severe, refractory cutaneous lupus erythematosus requiring hospitalization: Three cases and review of the literature	7
Lupus, antiphospholipid syndrome, and stroke: An attempt to crossmatch	7
Severe gastrointestinal manifestations in childhood-onset lupus: A single-center cohort and review of the literature	7
Real world application of the 2023 ACR/EULAR antiphospholipid antibody syndrome classification criteria in a pharmacist directed anticoagulation clinic	7
Efficacy and safety of telitacicept in the treatment of systemic lupus erythematosus: A retrospective real-world study	7
The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus	7
Systemic lupus erythematosus-related acute lung disease	7
Non-invasive prediction of the chronic degree of lupus nephropathy based on ultrasound radiomics	7
Drug-induced lupus erythematosus in childhood: Case-based review	7
Literature review of lupus nephritis From the Arabian Gulf region	7
Parkinsonism as the presenting manifestation of lupus: A case-based review	7
The experience and implications of pain in systemic lupus erythematosus: A qualitative interview study focusing on the patient’s perspective	7
Serum long non-coding Ribonucleic Acid H19 serves as a biomarker for systemic lupus erythematosus and participates in the disease progression	7
Association between interferon-I producing plasmacytoid dendritic cells and thrombotic antiphospholipid syndrome	6
Comparative efficacy of intravenous cyclophosphamide, mycophenolate mofetil, and tacrolimus as induction therapy for lupus nephritis: A randomized controlled open-label trial	6
Social impact of disease parameters and damage accrual in adult Brazilian patients with childhood-onset Systemic Lupus Erythematosus	6
Clinicopathologic features in childhood-onset lupus nephritis with antineutrophil cytoplasmic antibody positivity——a multi-center retrospective study	6
Evaluating the performance of four anti-dsDNA antibody detection methods	6
Anifrolumab for systemic lupus erythematosus with multi-refractory skin disease: A case series of 18 patients	6
Systemic lupus erythematosus and toll-like receptor 9 polymorphisms: A meta-analysis of genetic association studies	6
Trends in all-cause hospitalizations for systemic lupus erythematosus in Mexico, 2000–2019	6
Diving deep into lupus: Gastrointestinal involvement insights from the Oman lupus study	6
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study	6
The efficacy of induction treatment in Thai patients with lupus nephritis: Observational cohort analysis	6
What you need to know about migraine in Hughes syndrome patients	6
Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients	6
LncRNA NRIR serves as a biomarker for systemic lupus erythematosus and participates in the disease progression	6
Skin and beyond: Demographics, clinical features and systemic involvement of cutaneous lupus erythematosus in Pakistani population	6

Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score	6
Health-Related Quality of Life and fatigue are associated with a higher work productivity impairment in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort	6
Bilateral outer foveal microdefect in a patient with systemic lupus erythematosus using hydroxychloroquine - A case report	6
Utility of pan-immune-inflammation value as a predictor of the prognosis of childhood lupus	6
The effectiveness of telitacicept in patients with systemic lupus erythematosus: A retrospective, real-world study	6
Comparison of efficacy of continuous mycophenolate mofetil with sequential cyclophosphamide and tacrolimus as maintenance therapy for lupus nephritis	6
Skin erythematous migrant lesions consistent with histologically confirmed dermal arteriolar thrombosis connected to APS	6
Association of juvenile systemic lupus erythematosus and retinal vasculitis: Genetic aspects	6
Detection of genetic mutations underlying early-onset systemic lupus erythematosus	6
Abnormal presentation of pregnancy and postpartum initial-onset systemic lupus erythematosus combined with diffuse alveolar hemorrhage: A case report	6
Development and psychometric properties of the Reproductive Health Assessment in Systemic Lupus Erythematosus: Mixed-Methods study	6
Retrospective cohort study identifying pulmonary complications in a cohort of patients with systemic lupus erythematosus	6
Chorea associated with systemic lupus erythematosus- a systematic review	6
Validation and adaptation of the Spanish version of the systemic lupus activity questionnaire (S-SLAQ) in an Argentinean population	6
Efficacy of Telitacicept in a systemic lupus erythematosus patient with suboptimal response to Belimumab: A case report	6
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance	6
CAR-modified cells and the sisyphus myth: A new panacea for lupus?	5
APOL1 and the risk of adverse renal outcomes in patients of African ancestry with systemic lupus erythematosus	5
Unilateral lupus mastitis	5
Correlation between ABO blood group and clinical characteristics of patients with lupus nephritis	5
Factors affecting sleep quality in patients with systemic lupus erythematosus	5
Lupus anticoagulant-hypoprothrombinemia syndrome in children: Three case reports and systematic review of the literature	5
Systematic literature review of intravenous immunoglobulin use in non-renal and non-hematologic systemic lupus erytehmatosus	5
Complex relationships between inflammatory manifestations/type 1 and type 2 symptoms in systemic lupus erythematosus: A narrative literature review	5
Cost-effectiveness of cyclophosphamide and non-cyclophosphamide in the induction therapy of Malaysian lupus nephritis patients	5
Impact of perception of illness on quality of life in juvenile systemic lupus erythematosus	5
Phenotype and disease course differences in monogenic and sporadic childhood lupus	5
Systemic lupus erythematosus following COVID-19 vaccination. A systematic review of case reports and case series	5
Interferon-gamma (IFN-γ) intronic variant (rs2430561) is a risk factor for systemic lupus erythematosus: Observation from a meta-analysis	5
Systemic erythematosus lupus and pregnancy outcomes in a Colombian cohort	5
Status of TWEAK DNA methylation and mRNA expression in systemic lupus erythematosus	5
Risk factors analysis and risk assessment model construction of systemic lupus erythematosus patients with infection	5
Clinical and laboratory differences in pediatric-onset versus adult-onset lupus nephritis: A retrospective cohort analysis	5
The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family	5
Should asymptomatic bacteriuria be treated in lupus nephritis?	5
A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents.	5
Evaluation of thiol/disulfide hemostasis and serum Ischemia modified albumin as oxidative stress biomarkers in systemic lupus erythematosus patients: Relationship with major organ involvement and dise	5
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro	5
Insertion/deletion polymorphism of the angiotensin-converting enzyme gene in lupus nephritis at Cho Ray hospital, Vietnam	5
Ablation of SigH+ pDCs in B6.Nba2 mice prevents lupus-like disease development only if started before disease is fully established	5
National epidemiological analysis of lupus in Chile: A registry-based study from 2013 to 2024	5
Psychological and quality of life effects of vaccination against COVID-19 in patients with systemic autoimmune diseases	5
Diffuse alveolar haemorrhage in systemic lupus erythematosus: A multicentre retrospective study in Singapore	5
A review of the development of gangrene in patients with systemic lupus erythematosus – A 44-year follow-up study	5
Machine learning: Predicting hospital length of stay in patients admitted for lupus flares	5
Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-Yaa mice	5
Neutrophilic dermatoses as a manifestation of a systemic lupus erythematosus flare	5
Laryngeal and voice dysfunction in systemic lupus erythematosus patients – A case-control study	5
Prenatal predisposing factors associated with neonatal lupus erythematosus	5
Peripheral mononuclear cells and systemic lupus erythematosus association: Integrated study of single-cell sequencing and mendelian randomization analysis	5
Initiation of belimumab with higher daily prednisolone is effective for rapid glucocorticoid reduction: A 96-week retrospective study	5
Clinical efficacy of centrifugal-membranous hybrid double filtration plasmapheresis and membranous double filtration plasmapheresis on severe lupus nephritis	5
The impact of curcumin supplementation on systemic lupus erythematosus and lupus nephritis: A systematic review	5
Incidence and prevalence of systemic lupus erythematosus in New Zealand from the national administrative datasets	5
Predictive value of Doppler echocardiography parameters for cardiovascular events in patients with systemic lupus erythematosus	5